Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

466 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder.
Hansmann H, Henkel C, Fante MA, Harrer DC, Heidemanns S, Oellerich M, Beck J, Schütz E, Biswenger V, Perl M, Zartner B, Edinger M, Wolff D, Hoffmann P, Herr W, Banas B, Zecher D, Hansmann L. Hansmann H, et al. Among authors: perl m. Am J Transplant. 2025 Sep 17:S1600-6135(25)02986-7. doi: 10.1016/j.ajt.2025.09.009. Online ahead of print. Am J Transplant. 2025. PMID: 40972901 Free article.
CAR-T cell therapy and reconstructive oncologic surgery in peripheral solid tumors-A narrative review.
Knoedler L, Herfeld K, Schaefer DA, Diatta F, Clune J, Evans B, Seu M, Kim BS, Alfertshofer M, Schaschinger T, Iske J, Knoedler S, Lellouch AG, Jeljeli M, Carturan A, Ruella M, Heiland M, Poeck H, Perl M, Pomahac B, Kauke-Navarro M. Knoedler L, et al. Among authors: perl m. Cell Rep Med. 2025 Aug 19;6(8):102240. doi: 10.1016/j.xcrm.2025.102240. Epub 2025 Jul 16. Cell Rep Med. 2025. PMID: 40675157 Free PMC article. Review.
Gasdermin E links tumor cell-intrinsic nucleic acid signaling to proinflammatory cell death for successful checkpoint inhibitor cancer immunotherapy.
Enssle S, Sax A, May P, El Khawanky N, Soliman N, Perl M, Enssle JC, Krey K, Ruland J, Pichlmair A, Bassermann F, Poeck H, Heidegger S. Enssle S, et al. Among authors: perl m. Oncoimmunology. 2025 Dec;14(1):2504244. doi: 10.1080/2162402X.2025.2504244. Epub 2025 May 14. Oncoimmunology. 2025. PMID: 40366863 Free PMC article.
466 results